Issue link: https://www.e-digitaleditions.com/i/723777
An additional fee is required to attend any of the six short courses and five workshops offered Sunday, November 13. They address bioe- quivalence, managing excipients for QbD projects, excipient risk assess- ment, integrating material characteri- zation with in-silico modeling, tech- nologies that facilitate patient-friendly dosage forms, fundamentals of poly- mer science, and other topics. New this year are digital poster presenta- tions that allow you to view the posters on a screen, search them for content, and send an email to the authors. The conference officially starts Sunday at 4:30 pm with the keynote by Daniel A. Fletcher, a professor of bioengineering and biophysics at the University of California-Berkeley. He will discuss turning cell phones into inexpensive microscopes and how to use them in in the field and in resource-poor settings. Plenary speak- ers include Susan Hershenson of the Bill and Melinda Gates Foundation, who will address the global challenges to implementing pharmaceutical breakthroughs. Fredrick Balagadde of the KwaZulu-Natal Research Institute for TB and HIV will discuss "Lab-on-a- Chip Diagnostics for HIV: Barriers to Implementation," and James Olson of the Fred Hutchinson Cancer Research Center will discuss using "paint" and "optides" to treat tumors and cancer. The welcome reception that follows will be held on the exhibition floor. The annual meeting of the Amer- ican Association of Pharmaceutical Scientists (AAPS) takes place Nov- ember 13-17 in Denver, CO, bringing together more than 7,000 pharmaceu- tical professionals and 450 exhibitors. The conference will focus on four key themes: advancing product develop- ment through novel technology, new delivery modalities, enhancing patient lives through accelerated drug devel- opment, and precision medicine. Education More than 100 educational sessions are planned. Among the 53 symposia, topics include in-silico modeling and predictive dissolution, continuous manufacturing, in-situ characterization of solid dosage forms, assessing abuse- deterrent formulations, the processing and manufacturing challenges of pep- tides, 3D printing of solid dosage forms, and directly measuring dissolu- tion in the human GI tract. There will be 24 roundtables, which are now called dialogue and debate ses- sions. They include the gap between academic vision and industry reality, dissolution approaches to enable con- tinuous manufacturing, assigning blame when excipients fail, getting oral pep- tides to market, and assessing blend and content uniformity. Exposition The show floor opens to all atten- dees at 8:30 am, Monday, November 14, and remains open until 5:00 pm on Monday and Tuesday. It closes Wednesday at 1:30 pm. More than 450 companies are registered to exhibit. T&C Exhibitor list The following companies and orga- nizations are among those exhibiting at AAPS November 13-17 in Denver, CO. For a complete, updated list, visit www.aaps.org/AMExhibit. Company Booth A ACG Worldwide 801 Abitec 1235 Agilent Technologies 915 Alcami 303 Almac 320 Arizona Instrument 300 Ashland 927 B BASF 1227 Biddle Sawyer 942 Bosch Packaging 763 Brookfield Engineering 623 Buchi 626 Budenheim 1450 C CapsCanada 632 Capsugel 1101 Catalent 901 Coating Place 409 a preview AAPS Annual Meeting & Exposition Pharmaceutical science expo offers more than 100 educational sessions Tablets & Capsules September 2016 49